BACKGROUND/AIM: periodic measurement of plasma concentrations of cortisol precursors on a clinic visit may be of limited value in patients with congenital adrenal hyperplasia because it does not reflect a patient's circadian patterns of adrenal steroid secretion. Steroid profiling in dried blood spots (DBS) may allow for more frequent and sensitive monitoring. METHODS: we compared the agreement between 17α-hydroxyprogesterone (17-OHP) and androstenedione (D4A) levels determined from DBS samples and concurrently collected serum samples. Blood was drawn from 9 congenital adrenal hyperplasia patients every 4 h over a 24-hour period. Serum and DBS steroid levels were measured by liquid chromatography tandem mass spectrometry. RESULTS: DBS determinations of 17-OHP overestimated corresponding serum levels (mean difference 1.67 ng/ml), and underestimated D4A serum levels (mean difference 0.84 ng/ml). However, the DBS assay yielded excellent agreement (97%) with serum 17-OHP, but did considerably poorer for D4A (31%). CONCLUSIONS: our results indicate an excellent agreement between DBS and serum 17-OHP measurements to identify the peaks and troughs associated with an individual's circadian pattern. Larger-scale studies are required to evaluate the utility of DBS for home monitoring and to determine if more frequent monitoring leads to improved clinical outcomes. 2010 S. Karger AG, Basel.
BACKGROUND/AIM: periodic measurement of plasma concentrations of cortisol precursors on a clinic visit may be of limited value in patients with congenital adrenal hyperplasia because it does not reflect a patient's circadian patterns of adrenal steroid secretion. Steroid profiling in dried blood spots (DBS) may allow for more frequent and sensitive monitoring. METHODS: we compared the agreement between 17α-hydroxyprogesterone (17-OHP) and androstenedione (D4A) levels determined from DBS samples and concurrently collected serum samples. Blood was drawn from 9 congenital adrenal hyperplasiapatients every 4 h over a 24-hour period. Serum and DBSsteroid levels were measured by liquid chromatography tandem mass spectrometry. RESULTS:DBS determinations of 17-OHP overestimated corresponding serum levels (mean difference 1.67 ng/ml), and underestimated D4A serum levels (mean difference 0.84 ng/ml). However, the DBS assay yielded excellent agreement (97%) with serum 17-OHP, but did considerably poorer for D4A (31%). CONCLUSIONS: our results indicate an excellent agreement between DBS and serum 17-OHP measurements to identify the peaks and troughs associated with an individual's circadian pattern. Larger-scale studies are required to evaluate the utility of DBS for home monitoring and to determine if more frequent monitoring leads to improved clinical outcomes. 2010 S. Karger AG, Basel.
Authors: Jean M Lacey; Carla Z Minutti; Mark J Magera; Angela L Tauscher; Bruno Casetta; Mark McCann; James Lymp; Si Houn Hahn; Piero Rinaldo; Dietrich Matern Journal: Clin Chem Date: 2003-12-04 Impact factor: 8.327
Authors: Nike M M L Stikkelbroeck; Bep A E Van't Hof-Grootenboer; Ad R M M Hermus; Barto J Otten; Martin A Van't Hof Journal: J Clin Endocrinol Metab Date: 2003-08 Impact factor: 5.958
Authors: H J Van der Kamp; B J Otten; N Buitenweg; S M P F De Muinck Keizer-Schrama; W Oostdijk; M Jansen; H A Delemarre-de Waal; T Vulsma; J M Wit Journal: Arch Dis Child Date: 2002-08 Impact factor: 3.791
Authors: I Manoli; Ch Kanaka-Gantenbein; A Voutetakis; M Maniati-Christidi; C Dacou-Voutetakis Journal: Clin Endocrinol (Oxf) Date: 2002-11 Impact factor: 3.478
Authors: Carla Z Minutti; Jean M Lacey; Mark J Magera; Si Houn Hahn; Mark McCann; Andreas Schulze; David Cheillan; Claude Dorche; Donald H Chace; James F Lymp; Donald Zimmerman; Piero Rinaldo; Dietrich Matern Journal: J Clin Endocrinol Metab Date: 2004-08 Impact factor: 5.958